Spyre Therapeutics logo

Spyre Therapeutics Share Price Today

(NASDAQ: SYRE)

Spyre Therapeutics share price is $23.7 & ₹2,064.15 as on 5 Feb 2025, 2.30 'hrs' IST

$23.7

0.8

(3.49%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Spyre Therapeutics share price in Dollar and Rupees. Guide to invest in Spyre Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Spyre Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Spyre Therapeutics share price movements

  • Today's Low: $22.66
    Today's High: $23.84

    Day's Volatility :4.95%

  • 52 Weeks Low: $20.07
    52 Weeks High: $47.97

    52 Weeks Volatility :58.16%

Spyre Therapeutics (SYRE) Returns

PeriodSpyre Therapeutics IncIndex (Russel 2000)
3 Months
-36.77%
0.0%
6 Months
-3.46%
0.0%
1 Year
-7.17%
0.0%
3 Years
-78.41%
-11.7%

Spyre Therapeutics (SYRE) Key Statistics

in dollars & INR

Previous Close
$22.9
Open
$22.75
Today's High
$23.835
Today's Low
$22.655
Market Capitalization
$1.4B
Today's Volume
$634.9K
52 Week High
$47.97
52 Week Low
$20.07
Revenue TTM
$0.0
EBITDA
$-194.5M
Earnings Per Share (EPS)
$-37.75
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-91.62%

How to invest in Spyre Therapeutics Stock (SYRE) from India?

It is very easy for Indian residents to invest directly in Spyre Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Spyre Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Spyre Therapeutics or SYRE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Spyre Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Spyre Therapeutics shares which would translate to 0.037 fractional shares of Spyre Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Spyre Therapeutics, in just a few clicks!

Returns in Spyre Therapeutics (SYRE) for Indian investors in Rupees

The Spyre Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Spyre Therapeutics investment value today

Current value as on today

₹97,735

Returns

₹2,265

(-2.26%)

Returns from Spyre Therapeutics Stock

₹7,168 (-7.17%)

Dollar Returns

₹4,903 (+4.9%)

Indian investors sentiment towards Spyre Therapeutics (SYRE)

-83%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Spyre Therapeutics Stock from India on INDmoney has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Spyre Therapeutics

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Spyre Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
11
Hold
1
1
2
Sell
0
0
0

Analyst Forecast on Spyre Therapeutics Stock (SYRE)

What analysts predicted

Upside of 147.36%

Target:

$58.63

Current:

$23.70

Insights on Spyre Therapeutics Stock (Ticker Symbol: SYRE)

  • Price Movement

    In the last 7 days, SYRE stock has moved up by 8.2%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 168.0K → 1.04M (in $), with an average increase of 40.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -38.83M → -69.02M (in $), with an average decrease of 77.7% per quarter
  • SYRE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 65.2%
  • SYRE vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 86.4% return, outperforming this stock by 164.2%

Spyre Therapeutics Technicals Summary

Sell

Neutral

Buy

Spyre Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Spyre Therapeutics (SYRE) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Spyre Therapeutics Inc logo
-2.95%
-3.46%
-7.17%
-78.41%
-87.89%
Biontech Se logo
-2.55%
47.81%
22.02%
-32.21%
279.34%
Regeneron Pharmaceuticals, Inc. logo
-2.68%
-34.72%
-25.67%
12.0%
82.54%
Vertex Pharmaceuticals Incorporated logo
19.82%
3.52%
15.9%
98.26%
100.9%
Alnylam Pharmaceuticals, Inc. logo
16.23%
4.16%
57.39%
82.31%
115.97%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Spyre Therapeutics Inc logo
1.72
NA
NA
-4.33
-0.92
-0.39
NA
3.34
Biontech Se logo
160.8
NA
0.04
-3.37
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.49
16.49
1.08
44.92
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.21
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Spyre Therapeutics Inc logo
Buy
$1.4B
-87.89%
1.72
0.0%
Biontech Se logo
Buy
$28.7B
279.34%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.3B
82.54%
16.49
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$121.1B
100.9%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.4B
115.97%
NA
-15.86%

About Spyre Therapeutics

Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human monoclonal immunoglobulin G1 antibody designed to bind selectively to the a4ß7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn's disease). The company is also developing SPY002, a human monoclonal antibody (mAb)candidates designed to bind to tumor necrosis factor-like ligand 1A; and SPY120, a combination of SPY001 (anti-a4ß7) and SPY002 (anti-TL1A) antibodies, which are in preclinical studies. In addition, its other early-stage programs include SPY003, an anti-IL-23 mAb; SPY004, a novel mechanism of action (MOA) mAb; SPY130, a combination of anti-a4ß7 and anti-IL-23 mAbs; and SPY230, a combination of anti-TL1A and anti-IL-23 mAbs. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was incorporated in 2013 and is based in Waltham, Massachusetts.
Organization
Spyre Therapeutics
Employees
30
CEO
Dr. Cameron Turtle DPHIL, Ph.D.
Industry
Miscellaneous

Management People of Spyre Therapeutics

NameTitle
Dr. Cameron Turtle DPHIL, Ph.D.
CEO & Director
Mr. Scott L. Burrows
Chief Financial Officer
Ms. Heidy Abreu King-Jones J.D., L.L.M.
Chief Legal Officer & Corporate Secretary
Dr. Janet Gunzner-Toste M.B.A., Ph.D.
Senior Vice President of Operations
Mr. Brian Connolly
Chief Technical Officer
Mr. Eric McIntyre
Vice President of Finance & Investor Relations
Mr. James Myers
Vice President of Quality & Compliance
Dr. Kelly Boothe Ph.D.
Senior Director of Corporate Communications & Investor Relations
Dr. Justin LaFountaine Ph.D.
Senior Vice President of Corporate Development
Ms. Melissa Cooper
Senior Vice President of People

Important FAQs about investing in SYRE Stock from India :

What is Spyre Therapeutics share price today?

Spyre Therapeutics share price today stands at $23.70, Open: $22.75 ; Previous Close: $22.90 ; High: $23.84 ; Low: $22.66 ; 52 Week High: $47.97 ; 52 Week Low: $20.07.

The stock opens at $22.75, after a previous close of $22.90. The stock reached a daily high of $23.84 and a low of $22.66, with a 52-week high of $47.97 and a 52-week low of $20.07.

Can Indians buy Spyre Therapeutics shares?

Yes, Indians can invest in the Spyre Therapeutics (SYRE) from India.

With INDmoney, you can buy Spyre Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Spyre Therapeutics at zero transaction cost.

How can I buy Spyre Therapeutics shares from India?

It is very easy to buy Spyre Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Spyre Therapeutics (SYRE) be purchased?

Yes, you can buy fractional shares of Spyre Therapeutics with INDmoney app.

What are the documents required to start investing in Spyre Therapeutics stocks?

To start investing in Spyre Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Spyre Therapeutics Stock (SYRE)?

Today’s highest price of Spyre Therapeutics (SYRE) is $23.84.

Today’s lowest price of Spyre Therapeutics (SYRE) is $22.66.

What is today's market capitalisation of Spyre Therapeutics?

Today's market capitalisation of Spyre Therapeutics SYRE is 1.4B

What is the 52 Week High and Low Range of Spyre Therapeutics Stock (SYRE)?

  • 52 Week High

    $47.97

  • 52 Week Low

    $20.07

What are the historical returns of Spyre Therapeutics (SYRE)?

  • 1 Month Returns

    -2.95%

  • 3 Months Returns

    -3.46%

  • 1 Year Returns

    -7.17%

  • 5 Years Returns

    -87.89%

Who is the Chief Executive Officer (CEO) of Spyre Therapeutics ?

Dr. Cameron Turtle DPHIL, Ph.D. is the current Chief Executive Officer (CEO) of Spyre Therapeutics.